Well that was a significant buy $21K+ - seems someone thinks that under the offer price is a good price. I still think that they have a great asset but am concerned as to how much dilution loss there will be before it becomes profitable.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025